Recent publications on Cancer

Greene S, Gallagher T, Roblin D, Robinson B, Horner K, Firneno C, Prouty C, Mazor K. A GPS for navigating sensitive research topics: the case of adverse events in oncology. Clin Med Res. 2011;9(3-4):149. PubMed

Rosenberg RD, Haneuse SJ, Geller BM, Buist DS, Miglioretti DL, Brenner RJ, Smith-Bindman R, Taplin SH. Timeliness of follow-up after abnormal screening mammogram: variability of facilities Radiology. 2011 Nov;261(2):404-13. Epub 2011 Sep 7. PubMed

Klasnja P, Hartzler A, Powell C, Pratt W. Supporting cancer patients’ unanchored health information management with mobile technology. AMIA Annu Symp Proc. 2011;2011:732-41. Epub 2011 Oct 22. PubMed

Talcott JA, Yeap BY, Clark JA, Siegel RD, Loggers ET, Lu C, Godley PA. Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial. J Clin Oncol. 2011 Oct 20;29(30):3977-83. Epub 2011 Sep 19. PubMed

Lowry S, Aiello Bowles EJ, Anderson ML, Buist DS. Predictors of breast density change after hormone therapy cessation: results from the READ randomized trial. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2309-12. Epub 2011 Aug 3. PubMed

Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.  Ann Intern Med. 2011;155(8):481-92. PubMed

Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, Taplin SH, Sickles EA. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155(8):493-502. PubMed

Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG. Use of clinical history affects accuracy of interpretive performance of screening mammography.  J Clin Epidemiol. 2012 Feb;65(2):219-30. Epub 2011 Oct 15. PubMed

Hubbard R, Kerlikowske K, Buist D, Yankaskas B. Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits.  AJR Am J Roentgenol. 2011;197(4):W793. PubMed

Malone KE, Daling J, Doody DR, O'Brien CA, Resler AJ, Ostrander EA, Porter PL. Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.  Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2560-71. doi: 10.1158/1055-9965.EPI-11-0781. Epub 2011 Sep 29. PubMed

Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, Fraker DL, Guvakova MA. Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. Breast Cancer Res Treat. 2011 Sep;129(2):361-72. doi: 10.1007/s10549-010-1227-y. Epub 2010 Oct 26. PubMed

Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy MJ, Donaldson A, Dorkins H, Easton DF; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Freidman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL. Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Cancer Res. 2011 Sep 1;71(17):5792-805. doi: 10.1158/0008-5472.CAN-11-0773. Epub 2011 Jul 28. PubMed

Pocobelli G, Doherty JA, Voigt LF, Beresford SA, Hill DA, Chen C, Rossing MA, Holmes RS, Noor ZS, Weiss NS. Pregnancy history and risk of endometrial cancer. Epidemiology. 2011 Sep;22(5):638-45. doi: 10.1097/EDE.0b013e3182263018. PubMed

Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP. Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2120-6. Epub 2011 Aug 30. PubMed

Moyer VA, U.S. Preventive Services Task Force. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2011 Aug 16;155(4):246-51. Erratum in: Ann Intern Med. 2011 Sep 20;155(6):408. PubMed

Livingston RB, Barlow WE, Kash JJ, Albain KS, Gralow JR, Lew DL, Flaherty LE, Royce ME, Hortobagyi GN. SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.  Breast Cancer Res Treat. 2011 Nov;130(1):123-31. Epub 2011 Aug 9. PubMed

Fenton JJ, Abraham L, Taplin SH, Geller BM, Carney PA, D'Orsi C, Elmore JG, Barlow WE. Effectiveness of computer-aided detection in community mammography practice.  J Natl Cancer Inst. 2011;103(15):1152-1161. Epub 2011 Jul 27. PubMed

Perdue DG, Henderson JA, Garroutte E, Bogart A, Wen Y, Goldberg J, Buchwald D. Culture and colorectal cancer screening on three American Indian reservations. Ethn Dis. 2011 Summer;21(3):342-8. PubMed

Brunner RL, Wactawski-Wende J, Caan BJ, Cochrane BB, Chlebowski RT, Gass ML, Jacobs ET, Lacroix AZ, Lane D, Larson J, Margolis KL, Millen AE, Sarto GE, Vitolins MZ, Wallace RB. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer. 2011;63(6):827-41. Epub 2011 Jul 20. PubMed

Dillard AJ, Ubel PA, Smith DM, Zikmund-Fisher BJ, Nair V, Derry HA, Zhang A, Pitsch RK, Alford SH, McClure JB, Fagerlin A. The distinct role of comparative risk perceptions in a breast cancer prevention program. Ann Behav Med. 2011 Oct;42(2):262-8. PubMed